Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 23;101(3):adv00421.
doi: 10.2340/00015555-3784.

Incomplete Excisions of Melanocytic Lesions: Rates and Risk Factors

Affiliations

Incomplete Excisions of Melanocytic Lesions: Rates and Risk Factors

Sofia Berglund et al. Acta Derm Venereol. .

Abstract

Incomplete excisions of melanocytic lesions occur despite the intention of complete removal. The aim of this study was to determine the incomplete excision rates for benign and malignant melanocytic lesions and the associated risk factors. Demographic, clinical, and histo-pathological data possibly associated with incomplete excision were collected from 2,782 consecutive excisions between 2014 and 2015. Of these, 269 melanocytic lesions (9.7%) were incompletely excised. Multivariate analysis revealed the following risk factors for significantly higher incomplete excision rates: lesions located in the head and neck area (odds ratio (OR) 3.95, 95% confidence interval (95% CI) 2.35-6.65), surgery performed by general practitioners (OR 3.01, 95% CI 2.16-4.19), the use of a punch excision technique (OR 2.83, 95% CI 1.96-4.08), and excision of non-dysplastic naevi (OR 1.58, 95% CI 1.11-2.23). In conclusion, more caution should be taken when excising melanocytic lesions in the head and neck area, general practitioners require more surgical training, and punch excisions of melanocytic lesions should be avoided.

Keywords: melanocytic lesion; melanoma; naevus; surgery; incomplete excision.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Similar articles

References

    1. Eriksson T, Tinghög G. Societal cost of skin cancer in Sweden in 2011. Acta Derm Venereol 2015; 95: 347–348. - PubMed
    1. Guy GP, Jr., Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections – United States, 1982–2030. MMWR Morb Mortal Wkly Rep 2015; 64: 591–596. - PMC - PubMed
    1. Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, et al. . Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 2018; 92: 108–118. - PubMed
    1. National Cancer Control Indicators (NCCI) – Cancer Australia (Incidence, by sex, 1982–2019 melanoma); 2019. [cited 2020 Nov 12]. Available from: https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-in....
    1. NORDCAN . Cancer incidence, mortality, prevalence and prediction in the Nordic Countries; 2019. [cited 2020 Nov 12]. Available from http://www-dep.iarc.fr/NORDCAN/SW/frame.asp or http://www-dep.iarc.fr/NORDCAN/SW/StatsFact.asp?cancer=310&country=0.